Proscia Inc., a data solutions provider for digital pathology, announced today Proscia’s President and CEO, David West, will discuss how Maryland entrepreneurs can continue to be competitive in the quest for venture funding in a more risk-adverse environment. Drawing from his own experiences and successes, David will address what entrepreneurs need to achieve in order to secure investment and funding at TEDCO’s 7th annual Entrepreneur Expo & Stem Cell Symposium on October 25, 2017 at Hilton Baltimore.
“I am honored and pleased to be sharing my story as a successful entrepreneur in the Maryland biotechnology sector, says Mr. West. “Founding Proscia in 2014 while I was attending John’s Hopkins University has proven to be a challenging feat. Since then, with the help of our investors, Proscia has been recognized for its award-winning digital pathology software and has recently released a new clinical offering that will provide the launch-pad to the next-generation of precision medicine and analytic tools for computational pathology.”
Mr. West will be joined by Christopher College, Managing Partner at TCP Venture Capital, to provide an angel investor perspective on what made Proscia a break out start up worth investing in.
TEDCO is the go-to source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy. TEDCO’s 7th annual Entrepreneur Expo and Stem Cell Symposium, allows entrepreneurs and angel investors to build their knowledge and network, and celebrate Maryland’s innovation community.
Below are the details for David West’s panel presentation:
Title: Rising above the Bar: What it Takes to be Venture Backable
Location: Hilton Baltimore, 401 West Pratt Street, Baltimore, Maryland
Date/Time: Wednesday, October 25th, 9:45 – 10:45 a.m. EDT
Proscia was founded in 2014 by a team out of Johns Hopkins, the Moffitt Cancer Center, and the University of Pittsburgh to improve clinical outcomes and accelerate the discovery of breakthrough advancements in the fight against cancer. Using modern computing technologies that unlock hidden data not visible to the human eye and turning that data into valuable insights in the fight against cancer, the company is dedicated to improving the efficiency, speed and quality of pathology diagnostics and research. To learn more, please visit http://www.proscia.com.